# Pragmatic Optimized Rifampicin Trial

> **NCT06057519** · PHASE3 · RECRUITING · sponsor: **Radboud University Medical Center** · enrollment: 164 (estimated)

## Conditions studied

- Tuberculosis, Pulmonary

## Interventions

- **DRUG:** Optimised dose rifampicin
- **DRUG:** Standard dose rifampicin

## Key facts

- **NCT ID:** NCT06057519
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-16
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06057519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06057519, "Pragmatic Optimized Rifampicin Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06057519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*